<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microbiol Spectr</journal-id><journal-id journal-id-type="iso-abbrev">Microbiol Spectr</journal-id><journal-id journal-id-type="publisher-id">spectrum</journal-id><journal-title-group><journal-title>Microbiology Spectrum</journal-title></journal-title-group><issn pub-type="epub">2165-0497</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9241694</article-id><article-id pub-id-type="pmid">35510858</article-id><article-id pub-id-type="publisher-id">00493-22</article-id><article-id pub-id-type="doi">10.1128/spectrum.00493-22</article-id><article-id pub-id-type="publisher-id">spectrum.00493-22</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">antimicrobial-chemotherapy</compound-subject-part><compound-subject-part content-type="label">Antimicrobial Chemotherapy</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Mycothiol Peroxidase Activity as a Part of the Self-Resistance Mechanisms against the Antitumor Antibiotic Cosmomycin D</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0724-3959</contrib-id><name><surname>Castillo Arteaga</surname><given-names>Roger D.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><!--<xref ref-type="other" rid="cr1 cr2 cr3 cr4 cr5 cr6 cr7 cr8 cr9"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5311-1183</contrib-id><name><surname>Garrido</surname><given-names>Leandro M.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><!--<xref ref-type="other" rid="cr10 cr11 cr12 cr13 cr14 cr15 cr16 cr17 cr18 cr19"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2158-2807</contrib-id><name><surname>Pedre</surname><given-names>Brand&#x000e1;n</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref><!--<xref ref-type="other" rid="cr20 cr21"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8719-0999</contrib-id><name><surname>Helmle</surname><given-names>Irina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><!--<xref ref-type="other" rid="cr22 cr23 cr24"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0731-821X</contrib-id><name><surname>Gross</surname><given-names>Harald</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref><!--<xref ref-type="other" rid="cr25 cr26 cr27"/>--></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1265-0065</contrib-id><name><surname>Gust</surname><given-names>Bertolt</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref><!--<xref ref-type="other" rid="cr28 cr29 cr30 cr31 cr32 cr33"/>--></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8086-3065</contrib-id><name><surname>Padilla</surname><given-names>Gabriel</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><email>gpadilla@icb.usp.br</email><!--<xref ref-type="other" rid="cr34 cr35 cr36 cr37 cr38 cr39 cr40 cr41 cr42 cr43"/>--></contrib><aff id="aff1">
<label>a</label>
<addr-line>Pharmaceutical Institute, Department of Pharmaceutical Biology, <institution-wrap><institution>University of T&#x000fc;bingen</institution><institution-id institution-id-type="grid">grid.10392.39</institution-id></institution-wrap>, T&#x000fc;bingen, Germany</addr-line>
</aff><aff id="aff2">
<label>b</label>
<addr-line>Institute of Biomedical Sciences, University of S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil</addr-line>
</aff><aff id="aff3">
<label>c</label>
<addr-line>Division of Redox Regulation, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany</addr-line>
</aff><aff id="aff4">
<label>d</label>
<addr-line>German Center for Infection Research (DZIF), Partner Site T&#x000fc;bingen, T&#x000fc;bingen, Germany</addr-line>
</aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>de Carvalho</surname><given-names>Luiz Pedro Sorio</given-names></name><aff>Francis Crick Institute</aff></contrib></contrib-group><author-notes><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="pub"><day>5</day><month>5</month><year>2022</year></pub-date><pub-date publication-format="electronic" date-type="collection"><season>May-Jun</season><year>2022</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>5</month><year>2022</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>10</volume><issue>3</issue><elocation-id>e00493-22</elocation-id><history>
<date date-type="received"><day>11</day><month>2</month><year>2022</year></date>
<date date-type="accepted"><day>13</day><month>4</month><year>2022</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2022 Castillo Arteaga et al.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Castillo Arteaga et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2022-05-05"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="spectrum.00493-22.pdf"/><abstract><title>ABSTRACT</title><p>Antibiotic-producing microorganisms usually require one or more self-resistance determinants to survive antibiotic production. The effectors of these mechanisms are proteins that inactivate the antibiotic, facilitate its transport, or modify the target to render it insensitive to the molecule. <named-content content-type="genus-species">Streptomyces</named-content> bacteria biosynthesize various bioactive natural products and possess resistance systems for most metabolites, which are coregulated with antibiotic biosynthesis genes. <named-content content-type="genus-species">Streptomyces olindensis</named-content> strain DAUFPE 5622 produces the antitumor antibiotic cosmomycin D (COSD), a member of the anthracycline family. In this study, we propose three self-resistance mechanisms, anchored or based in the COSD biosynthetic gene cluster. These include <italic toggle="yes">cosIJ</italic> (an ABC transporter), <italic toggle="yes">cosU</italic> (a UvrA class IIa protein), and a new self-resistance mechanism encoded by <italic toggle="yes">cosP</italic>, which shows response against peroxides by the enzyme mycothiol peroxidase (MPx). Activity-based investigations of MPx and its mutant enzyme confirmed peroxidation during the production of COSD. Overexpression of the ABC transporter, the UvrA class IIa protein, and the MPx led to an effective response against toxic anthracyclines, such as cosmomycins. Our findings help to understand how thiol peroxidases play an antioxidant role in the anthracycline producer <named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622, a mechanism which has been reported for neoplastic cells that are resistant to doxorubicin (DOX).</p><p><bold>IMPORTANCE</bold> Anthracycline compounds are DNA intercalating agents widely used in cancer chemotherapeutic protocols. This work focused on the self-resistance mechanisms developed by the cosmomycin-producing bacterium <named-content content-type="genus-species">Streptomyces olindensis</named-content>. Our findings showed that cysteine peroxidases, such as mycothiol peroxidase, encoded by the gene <italic toggle="yes">cosP</italic>, protected <named-content content-type="genus-species">S. olindensis</named-content> against peroxidation during cosmomycin production. This observation can contribute to much better understanding of resistance both in the producers, eventually enhancing production, and in some tumoral cell lines.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>self-resistance mechanisms</kwd><kwd><italic toggle="yes">Streptomyces olindensis</italic></kwd><kwd>cosmomycin D</kwd><kwd>mycothiol peroxidase</kwd><kwd>reactive oxygen species</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award1"><funding-source id="GS1">
<institution-wrap><institution>Deutscher Akademischer Austauschdienst (DAAD)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001655</institution-id></institution-wrap>
</funding-source><award-id>57299294</award-id><principal-award-recipient>
<name><surname>Arteaga</surname><given-names>Roger David Castillo</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award2"><funding-source id="GS2">
<institution-wrap><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (FAPESP)</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001807</institution-id></institution-wrap>
</funding-source><award-id>09/52664-4</award-id><principal-award-recipient>
<name><surname>Padilla</surname><given-names>Gabriel</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="1" count-type="supplementary-material"/><fig-count count="7"/><table-count count="2"/><equation-count count="0"/><ref-count count="54"/><page-count count="13"/><word-count count="8591"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>May/June 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Anthracyclines are part of the polyketide type II family and are an important group of natural compounds produced by actinobacteria. The basic structure contains an aglycone skeleton and 6-deoxyhexose moieties, biosynthetically derived from glucose-1-phosphate. The two anthracyclines reported first were isolated from the pigment producer <named-content content-type="genus-species">Streptomyces peucetius</named-content> and were named doxorubicin (DOX) and daunorubicin (DNR) (<xref rid="B1" ref-type="bibr">1</xref>). Anthracyclines are clinically important compounds and are widely used to date for the treatment of different cancers, such as breast cancer, lymphomas, acute leukemia, neuroblastomas, and bone and soft tissue sarcomas (<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">&#x02013;</xref><xref rid="B4" ref-type="bibr">4</xref>). <named-content content-type="genus-species">Streptomyces olindensis</named-content> strain DAUFPE 5622 produces a purple-pigmented anthracycline with both antimicrobial activity (e.g., a MIC of 0.01&#x02009;&#x003bc;g/mL against <named-content content-type="genus-species">Staphylococcus aureus</named-content> strain ATCC 29213) and antitumoral activity (e.g., a 50% inhibitory concentration [IC<sub>50</sub>] of 0.110&#x02009;&#x003bc;g/mL against the HeLa human cervical carcinoma cell line) (<xref rid="B5" ref-type="bibr">5</xref>). Structural studies determined that the molecule, called cosmomycin D (COSD), is an aromatic complex with two trisaccharide chains attached at positions C-7 and C-10 on the aglycone (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Cosmomycins are an interesting group of compounds because they show one of the most complex glycosylation patterns found in anthracyclines, with position C-10 less frequently glycosylated than position C-7 (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>Antitumor-antibiotic-producing microorganisms must be protected from the lethal effects of their own products. The ability inherent in the producer organisms is called self-resistance. An understanding of the underlying mechanisms of drug resistance of pathogenic bacteria and self-resistance mechanisms of antitumor-antibiotic-producing microorganisms is important to develop therapeutic drugs for the treatment of infectious diseases (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). Antibiotic-producing microorganisms have a system that leads to transcription of the antibiotic-biosynthesizing genes at an appropriate time. To act effectively for self-resistance to its own antibiotic, antibiotic-modifying enzymes, target-protecting enzymes, antibiotic excretion systems, or DNA repair mechanisms must be present in the producer organisms when the biosynthetic pathway begins to produce the antibiotic (<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">&#x02013;</xref><xref rid="B11" ref-type="bibr">11</xref>).</p><p>The resistance mechanisms found in some anthracycline producers, such as <named-content content-type="genus-species">S. peucetius</named-content>, occur by the action of DrrA and DrrB, members of the ABC family of membrane transporters, which influence the efflux of DOX and DNR by the formation of an ABC transporter complex comprised of an ATPase and a transmembrane protein (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref><xref rid="B13" ref-type="bibr">&#x02013;</xref><xref rid="B14" ref-type="bibr">14</xref>). The second mechanism involves an inhibition or destabilization of the binding of DOX and DNR to genomic DNA by the action of the gene product of <italic toggle="yes">drrC</italic>, which codes for a protein with similarity to bacterial UvrA (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B13" ref-type="bibr">13</xref><xref rid="B14" ref-type="bibr">&#x02013;</xref><xref rid="B15" ref-type="bibr">15</xref>).</p><p>In comparison with other anthracyclines, COSD exhibits a high toxicity (<xref rid="B16" ref-type="bibr">16</xref>), which leads to the hypothesis that this strain must possess additional or optimized self-resistance strategies. In the biosynthetic gene cluster (BGC), we identified a gene encoding a mycothiol peroxidase (MPx) inside the cosmomycin cluster, adjacent to other resistance genes that were very similar to those reported in other actinobacteria that use the low-molecular-weight thiol mycothiol (MSH) (<xref rid="B17" ref-type="bibr">17</xref>). MPx is a thiol peroxidase that belongs to the cysteine glutathione peroxidase (CysGPx)-like enzyme family, having the S-mycothiolation of the MPx as part of its H<sub>2</sub>O<sub>2</sub> catalytic mechanism involved in controlling the reactive oxygen species (ROS) levels (<xref rid="B17" ref-type="bibr">17</xref>). There are two MPx paralog genes in the <named-content content-type="genus-species">S. olindensis</named-content> genome, while other species, such as <named-content content-type="genus-species">Streptomyces coelicolor</named-content> and <named-content content-type="genus-species">Streptomyces avermitilis</named-content>, have only one MPx.</p><p>We observed for the first time that MPx can reduce a cysteine&#x02013;MSH mixed disulfide, using a dithiol disulfide exchange mechanism, during the biosynthesis of COSD. Purification and identification of the MPx protein provided evidence that ROS-detoxifying proteins are employed by anthracycline producers. We describe in this study three self-resistance mechanisms against COSD in <named-content content-type="genus-species">S. olindensis</named-content>. The genes <italic toggle="yes">cosI</italic> and <italic toggle="yes">cosJ</italic> encode the first mechanism, an ABC transporter efflux system, while the second mechanism, encoded by <italic toggle="yes">cosU</italic>, is similar to <italic toggle="yes">drrC</italic> of <named-content content-type="genus-species">S. peucetius</named-content> and UvrA class IIa homologue proteins. Finally, a novel third mechanism, a mycothiol peroxidase (MPx) encoded by <italic toggle="yes">cosP</italic>, is involved in the detoxification of H<sub>2</sub>O<sub>2</sub>.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title>Self-resistance genes allocated within the cosmomycin D cluster.</title><p>Analysis of the COSD biosynthetic gene cluster, located at contig 2 of the genome assembly of <named-content content-type="genus-species">S. olindensis</named-content> (JJOH00000002.1), enabled the assignment of each gene based on their homology to genes coding for proteins of known functions. The genes <italic toggle="yes">cosI</italic> (DF19_23560), <italic toggle="yes">cosJ</italic> (DF19_23565), <italic toggle="yes">cosP</italic> (DF19_23570), and <italic toggle="yes">cosU</italic> (DF19_23575) were identified as four candidate genes that might play a role concerning self-resistance. The products of <italic toggle="yes">cosI</italic> and <italic toggle="yes">cosJ</italic> are part of a superfamily of transport proteins (ABC transporters) that is one of the largest groups of proteins in nature (<xref rid="B18" ref-type="bibr">18</xref>). In detail, <italic toggle="yes">cosI</italic> codes for a nucleotide-binding domain (NBD). The amino acid sequence encoded by <italic toggle="yes">cosI</italic> shows the same features found in the prototypal anthracycline resistance protein DrrA from <named-content content-type="genus-species">S. peucetius</named-content>, such as the Walker A motif, Q loop, signature motif, Walker B motif, switch region, GATE (glycine loop and transducer element) domain, and DEF motif (<xref rid="B19" ref-type="bibr">19</xref>). This component is associated with transmembrane proteins that are responsible for the formation of pores through which substances are transported, known as transmembrane domains (TMDs) (<xref rid="B20" ref-type="bibr">20</xref>). The analysis of the product of <italic toggle="yes">cosJ</italic> shows a typical conformation of the TMD, composed of alpha helices organized as homodimers (<xref rid="B21" ref-type="bibr">21</xref>). Both proteins form part of the ABC transporter complex, which has 95.14% identity to the ABC transporter of <named-content content-type="genus-species">Streptomyces purpurascens</named-content> (accession numbers <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_189725841.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_189725841.1</ext-link> and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_189725842.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_189725842.1</ext-link>, respectively) (Fig. S2 in the supplemental material). For CosJ, six transmembrane helices, forming a transmembrane domain, can be predicted using Phyre and TMHMM (Fig. S1).</p><p>In close proximity to <italic toggle="yes">cosI</italic> and <italic toggle="yes">cosJ</italic>, <italic toggle="yes">cosP</italic> could be identified as another plausible resistance determinant. It encodes an enzyme (accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link>) that shows 88.34% identity on the amino acid level with the glutathione peroxidase (GPx) from <named-content content-type="genus-species">S. purpurascens</named-content> (accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/GHA30648.1" ext-link-type="uri" assigning-authority="ncbiprotein">GHA30648.1</ext-link>). Although proteins of this kind are commonly annotated as glutathione peroxidases, those in actinobacteria in fact represent mycothiol peroxidases, as enzymatically demonstrated in the protein with accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/ASW14906.1" ext-link-type="uri" assigning-authority="ncbiprotein">ASW14906.1</ext-link> from <named-content content-type="genus-species">Corynebacterium glutamicum</named-content> (<xref rid="B17" ref-type="bibr">17</xref>).</p><p>Besides the gene encoding <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link>, there is a second gene annotated with this function in the genome, with locus tag DF19_33265, which is found in contig 4 (JJOH00000004.1) and encodes the protein with accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN79115.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN79115.1</ext-link>. When we compared both proteins with the MPx of <named-content content-type="genus-species">C. glutamicum</named-content> (accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/ASW14906.1" ext-link-type="uri" assigning-authority="ncbiprotein">ASW14906.1</ext-link>), <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN79115.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN79115.1</ext-link> showed a higher identity level (53.21%) than CosP (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link>) (43.4%), which resulted in higher values for the BLAST score and E value, which were, respectively, 175 and 2e&#x02212;57 for <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN79115.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN79115.1</ext-link> and 139 and 3e&#x02212;43 for <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link>. When <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN79115.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN79115.1</ext-link> were compared, they shared 55.1% identity.</p><p>Searching selected <named-content content-type="genus-species">Streptomyces</named-content> reference genomes for annotated GPx or MPx genes, we found in general only one ortholog per genome, such as those that encode the proteins with accession numbers <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAB88451.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAB88451.1</ext-link> in <named-content content-type="genus-species">S. coelicolor</named-content> strain A3(2), <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_010985209.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_010985209.1</ext-link> in <named-content content-type="genus-species">S. avermitilis</named-content>, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_100106014.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_100106014.1</ext-link> in <named-content content-type="genus-species">S. peucetius</named-content> subsp. <italic toggle="yes">caesius</italic> strain ATCC 27952, and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/EFL32854.1" ext-link-type="uri" assigning-authority="ncbiprotein">EFL32854.1</ext-link> in <named-content content-type="genus-species">Streptomyces viridochromogenes</named-content> strain DSM 40736 (Fig. S3). To understand how both annotated peroxidases of <named-content content-type="genus-species">S. olindensis</named-content> correlate with these proteins and with the remaining members of the GPx family in Pfam (accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link>), similarity sequence networks (SSNs) were constructed.</p><p>Since <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> was not in the UniProt database, first a small SSN with 100 proteins, denominated &#x0201c;seed,&#x0201d; was generated with the Enzyme Similarity Tool (<xref rid="B22" ref-type="bibr">22</xref>) and the FASTA sequence of <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> (Fig. S5), with the aim of identifying close relatives of <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> within the GPx family in Pfam. Since an identity level of 60% or higher was assumed to be sufficient to identify isofunctional protein clusters (<xref rid="B22" ref-type="bibr">22</xref>), we chose a level of 70% identity as the threshold in the seed SSN, where cluster 2 contained <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> and a further 12 members, listed in Table S2.</p><p>A first SSN of Pfam family <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link> was obtained using a threshold of about 55% similarity (Fig. S6); a large main cluster of 39,799 peroxidases included almost all actinobacterial proteins, together with those from other phyla, including known prokaryotic (e.g., BtuE of <named-content content-type="genus-species">Escherichia coli</named-content> [accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/P06610" ext-link-type="uri" assigning-authority="ncbiprotein">P06610</ext-link>]) and eukaryotic (e.g., GPx1 of <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> [accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/P36014" ext-link-type="uri" assigning-authority="ncbiprotein">P36014</ext-link>]) GPx proteins. When the threshold was increased to a similarity level of about 61% in a second <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link> SSN, the actinobacterial proteins grouped in different clusters. Cluster 2 comprised 3,261 proteins and included the proteins with accession numbers <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAB88451.1" ext-link-type="uri" assigning-authority="ncbiprotein">CAB88451.1</ext-link>, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_010985209.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_010985209.1</ext-link>, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_100106014.1" ext-link-type="uri" assigning-authority="ncbiprotein">WP_100106014.1</ext-link>, and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/EFL32854.1" ext-link-type="uri" assigning-authority="ncbiprotein">EFL32854.1</ext-link>; however, cluster 99 had almost the same composition as seed SSN cluster 2, excluding only <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> (Fig. S7 and Table S2), which is not in the <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link> database.</p><p>Subsequently, a genome neighborhood network (GNN) was generated from that SSN (Fig. S8). The analysis of cluster 99 revealed that all members were in non-previously described cosmomycin clusters of different <named-content content-type="genus-species">Streptomyces</named-content> species. These findings could suggest that <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> has an increased specificity for some peroxides generated by cosmomycin action.</p><p>The third putative resistance mechanism is encoded by <italic toggle="yes">cosU</italic>, whose product shows 96.71% similarity to the excinuclease ABC subunit UvrA of <named-content content-type="genus-species">Streptomyces janthinus</named-content> (accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/WP_193483046" ext-link-type="uri" assigning-authority="ncbiprotein">WP_193483046</ext-link>) (Fig. S4), which is a member of a group of proteins associated with DNA repair (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B23" ref-type="bibr">23</xref>). The prototype of this group is DrrC from <named-content content-type="genus-species">S. peucetius</named-content>, which could bind to daunorubicin intercalated to DNA and displace anthracycline, thereby preventing nucleic acid damage and allowing the drug to be expelled by the DrrA/-B system (<xref rid="B23" ref-type="bibr">23</xref>).</p></sec><sec id="s2-2"><title>Self-resistance mechanisms are essential for <italic toggle="yes">S. olindensis</italic> when challenged with DOX and COSD.</title><p>To understand the toxicity of COSD compared with that of pure DOX, COSD was isolated from <named-content content-type="genus-species">S. olindensis</named-content> using analytical fractionation. The fraction of interest showed a red-purple color. High-resolution mass spectrometry (HR-MS) measurements revealed a candidate compound with protonated molecular masses of <italic toggle="yes">m/z</italic> 1,189.5901 ([M&#x000a0;+&#x000a0;H]<sup>+</sup>, calculated 1,189.590149, &#x00394;&#x000a0;=&#x000a0;&#x02212;0.04&#x02009;ppm) and <italic toggle="yes">m/z</italic> 595.2991 ([M&#x02009;+&#x02009;2H]<sup>2+</sup>, calculated 595.298713, &#x00394; = +0.65&#x02009;ppm), which were consistent with the molecular formula of COSD (C<sub>60</sub>H<sub>88</sub>N<sub>2</sub>O<sub>22</sub>) (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>). A complementary tandem mass spectrometry (MS/MS) analysis of COSD, executed on its [M&#x02009;+&#x02009;2H]<sup>2+</sup> ion, produced fragment ions that were in full agreement with the expected structure (Fig. S9 and Table S1).</p><fig position="float" id="fig1"><label>FIG&#x000a0;1</label><caption><p>(A) Chemical structures of doxorubicin (DOX) and cosmomycin D (COSD). (B) HPLC profiles of COSD and DOX.</p></caption><graphic xlink:href="spectrum.00493-22-f001" position="anchor"/></fig><p>The hypothetical self-resistance genes <italic toggle="yes">cosI</italic>, <italic toggle="yes">cosJ</italic>, <italic toggle="yes">cosP</italic>, and <italic toggle="yes">cosU</italic> were cloned into the expression plasmid pUWL_Apra_oriT, generating the recombinant constructs pRCWL04 (<italic toggle="yes">cosI cosJ</italic>), pRCWL05 (<italic toggle="yes">cosP</italic>), and pRCWL06 (<italic toggle="yes">cosU</italic>). Exconjugants of <named-content content-type="genus-species">S. lividans</named-content> strain TK24 carrying the corresponding constructs, as well as the empty vector, were used to determine the MICs (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>) in a 96-well-plate assay format against COSD and doxorubicin (DOX) (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). As controls, <named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. peucetius</named-content> were used.</p><fig position="float" id="fig2"><label>FIG&#x000a0;2</label><caption><p>MICs of COSD and DOX for selected <named-content content-type="genus-species">Streptomyces</named-content> species by 96-well-plate assay. <named-content content-type="genus-species">S. peucetius</named-content> DSM 40754, <named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622, <named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL04 (<italic toggle="yes">cosI cosJ</italic>), <named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL05 (<italic toggle="yes">cosP</italic>), <named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL06 (<italic toggle="yes">cosU</italic>), and <named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL (empty vector) were challenged with DOX (A) or COSD (B). Final concentrations of DOX and COSD were 0, 1, 2, 4, 8, 16, 32, 64, and 128&#x02009;&#x003bc;g/mL for both antibiotics (apramycin was added at 50&#x02009;&#x003bc;g/mL when needed).</p></caption><graphic xlink:href="spectrum.00493-22-f002" position="anchor"/></fig><table-wrap position="float" id="tab1"><label>TABLE&#x000a0;1</label><caption><p>MICs of doxorubicin and cosmomycin D against <named-content content-type="genus-species">Streptomyces</named-content> strains</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Strain</th><th colspan="2" rowspan="1">MIC (&#x003bc;g/mL) of:<hr/></th></tr><tr><th rowspan="1" colspan="1">Doxorubicin</th><th rowspan="1" colspan="1">Cosmomycin D</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. peucetius</named-content> DSM 40754</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL04 (<italic toggle="yes">cosIJ</italic>)</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL05 (c<italic toggle="yes">osP</italic>)</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">4</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL06 (<italic toggle="yes">cosU</italic>)</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL (empty vector)</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2</td></tr></tbody></table><graphic xlink:href="spectrum.00493-22-t001" position="anchor"/></alternatives></table-wrap><p>The endogenous resistance to COSD of <named-content content-type="genus-species">S. lividans</named-content> TK24 was 2&#x02009;&#x003bc;g/mL; nevertheless, when it harbored the <italic toggle="yes">cosI</italic> and <italic toggle="yes">cosJ</italic> genes or the <italic toggle="yes">cosU</italic> gene, the resistance to COSD increased to the same level as that of <named-content content-type="genus-species">S. olindensis</named-content> (8&#x02009;&#x003bc;g/mL). The recombinant containing the mycothiol peroxidase (<italic toggle="yes">cosP</italic>) did not reach this concentration, but it hit the concentration achieved by <named-content content-type="genus-species">S. peucetius</named-content> strain DSM 40754 (4&#x02009;&#x003bc;g/mL). In a similar pattern, the <italic toggle="yes">cosI</italic> and <italic toggle="yes">cosJ</italic> genes or the <italic toggle="yes">cosU</italic> gene conferred higher resistance to DOX (16&#x02009;&#x003bc;g/mL) than did <italic toggle="yes">cosP</italic> (8&#x02009;&#x003bc;g/mL).</p><p><named-content content-type="genus-species">S. olindensis</named-content> had a resistance to DOX similar to that of <named-content content-type="genus-species">S. peucetius</named-content>; however, for COSD, <named-content content-type="genus-species">S. olindensis</named-content> was more resistant (8&#x02009;&#x003bc;g/mL versus 4&#x02009;&#x003bc;g/mL). On the other hand, <named-content content-type="genus-species">S. lividans</named-content> TK24 containing the empty pUWL vector did not show survival when exposed to COSD and DOX concentrations higher than 1&#x02009;&#x003bc;g/mL.</p></sec><sec id="s2-3"><title>Self-resistance genes are mostly expressed during the production of COSD.</title><p>We hypothesized that the <named-content content-type="genus-species">S. olindensis</named-content> wild-type (WT) strain overexpresses its self-resistance genes during production of the antibiotic. Thus, the expression levels of these genes were determined by quantitative PCR (qPCR) both during COSD production at 72&#x000a0;h and when COSD production was not detectable, at 24&#x000a0;h of cultivation (<xref rid="B6" ref-type="bibr">6</xref>). The endogenous gene <italic toggle="yes">hrdB</italic> (<xref rid="B24" ref-type="bibr">24</xref>) served as the reference (Fig. S10). For all genes, it was possible to confirm overexpression during the time when cosmomycin was produced compared with their expression levels during the cultivation stage when COSD was not yet detected (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>).</p><fig position="float" id="fig3"><label>FIG&#x000a0;3</label><caption><p>qPCR of <italic toggle="yes">cosI</italic>, <italic toggle="yes">cosJ</italic>, <italic toggle="yes">cosP</italic>, and <italic toggle="yes">cosU</italic>, with <italic toggle="yes">hrdB</italic> as the reference, during production (P) (72 h of cultivation) and nonproduction (N) (24&#x000a0;h of cultivation) of COSD by <named-content content-type="genus-species">S. olindensis</named-content>. Values are means of triplicate determinations &#x000b1; standard deviations (SD).</p></caption><graphic xlink:href="spectrum.00493-22-f003" position="anchor"/></fig></sec><sec id="s2-4"><title>MPx response against ROS stress.</title><p>The mycothiol peroxidase (MPx) from <named-content content-type="genus-species">S. olindensis</named-content> consists of 163 amino acids, three of which are Cys residues (C38, C66, and C84). Additionally, we purified a C38S mutant enzyme of MPx (bearing a mutation of Cys to Ser at position 38), obtained by site-directed mutagenesis (Fig. S11). We evaluated the peroxidase activity of both enzymes by ferrous oxidation of xylenol orange (FOX) assay to quantify H<sub>2</sub>O<sub>2</sub> and <italic toggle="yes">t</italic>-butyl hydroperoxide (tBOOH) reduction within a time frame of 180&#x000a0;s. The WT MPx consumed the majority of H<sub>2</sub>O<sub>2</sub> within 15&#x000a0;s, whereas the C38S mutant enzyme remained catalytically inactive, demonstrated by a constant amount of H<sub>2</sub>O<sub>2</sub> remaining in the assay over the time used. The FOX assay performed with tBOOH showed a significant decrease in the concentration of tBOOH, although the consumption rate was slower than in the case of H<sub>2</sub>O<sub>2</sub>, as only half of the tBOOH was reduced after 180s (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>).</p><fig position="float" id="fig4"><label>FIG&#x000a0;4</label><caption><p>H<sub>2</sub>O<sub>2</sub> and tBOOH quantification (FOX assay) of MPx WT and MPx C38S during 180&#x000a0;s of activity. Values are means of triplicate determinations &#x000b1; SD.</p></caption><graphic xlink:href="spectrum.00493-22-f004" position="anchor"/></fig><p>We also evaluated the MICs of H<sub>2</sub>O<sub>2</sub> against <named-content content-type="genus-species">S. olindensis</named-content>, <named-content content-type="genus-species">S. peucetius</named-content>, and <named-content content-type="genus-species">S. lividans</named-content> (1 to 512&#x02009;mM). For the concentrations tested, both of the anthracycline producers <named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. peucetius</named-content> survived 128&#x02009;mM H<sub>2</sub>O<sub>2</sub>, thereby confirming a good response against H<sub>2</sub>O<sub>2</sub>. <named-content content-type="genus-species">S. lividans</named-content> was very sensitive to H<sub>2</sub>O<sub>2</sub> (MIC of 8&#x02009;mM) (<xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>), but its resistance to H<sub>2</sub>O<sub>2</sub> improved notably when it contained a vector expressing <italic toggle="yes">cosP</italic>, showing a MIC of 32&#x02009;mM (<xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref> and <xref rid="tab2" ref-type="table">Table&#x000a0;2</xref>). This result indicates that MPx relieves this stress on <named-content content-type="genus-species">S. olindensis</named-content>, allowing it to survive persistent oxidative conditions.</p><fig position="float" id="fig5"><label>FIG&#x000a0;5</label><caption><p>MICs for selected <named-content content-type="genus-species">Streptomyces</named-content> species against H<sub>2</sub>O<sub>2</sub> in a 96-well-plate assay. <named-content content-type="genus-species">S. peucetius</named-content> DSM 40754, <named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622, <named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL05 (<italic toggle="yes">cosP</italic>), and <named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL (empty vector) were challenged with H<sub>2</sub>O<sub>2</sub> at the indicated concentrations.</p></caption><graphic xlink:href="spectrum.00493-22-f005" position="anchor"/></fig><table-wrap position="float" id="tab2"><label>TABLE&#x000a0;2</label><caption><p>MICs of H<sub>2</sub>O<sub>2</sub> against <named-content content-type="genus-species">Streptomyces</named-content> strains</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Strain</th><th rowspan="1" colspan="1">MIC (mM) of H<sub>2</sub>O<sub>2</sub></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. peucetius</named-content> DSM 40754</td><td rowspan="1" colspan="1">128</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622</td><td rowspan="1" colspan="1">128</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL (empty vector)</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1"><named-content content-type="genus-species">S. lividans</named-content> TK24/pRCWL05 (<italic toggle="yes">cosP</italic>)</td><td rowspan="1" colspan="1">32</td></tr></tbody></table><graphic xlink:href="spectrum.00493-22-t002" position="anchor"/></alternatives></table-wrap></sec><sec id="s2-5"><title><italic toggle="yes">S. olindensis</italic> peroxidase detoxification is important for survival during cosmomycin D production.</title><p>To understand the role of CosP in <named-content content-type="genus-species">S. olindensis</named-content> H<sub>2</sub>O<sub>2</sub> consumption, we evaluated the capacity of COSD producer <named-content content-type="genus-species">S. olindensis</named-content> and nonproducer <named-content content-type="genus-species">S. lividans</named-content> to reduce H<sub>2</sub>O<sub>2</sub> over time, under conditions that favor COSD production. For this, we measured the rates of H<sub>2</sub>O<sub>2</sub> consumption of total protein extracts at 24, 48, and 72&#x000a0;h of growth (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref>). While both <named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. lividans</named-content> improved their H<sub>2</sub>O<sub>2</sub> consumption rates at later growth stages, it was obvious that the <italic toggle="yes">cosP</italic> producer <named-content content-type="genus-species">S. olindensis</named-content> reduced H<sub>2</sub>O<sub>2</sub> faster (<xref rid="fig6" ref-type="fig">Fig.&#x000a0;6</xref>).</p><fig position="float" id="fig6"><label>FIG&#x000a0;6</label><caption><p>H<sub>2</sub>O<sub>2</sub> quantification (FOX assay) of <named-content content-type="genus-species">S. olindensis</named-content> WT versus <named-content content-type="genus-species">S. lividans</named-content> TK24 during 600&#x000a0;s of activity. Values are means of triplicate determinations &#x000b1; SD.</p></caption><graphic xlink:href="spectrum.00493-22-f006" position="anchor"/></fig></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>In this work, we highlighted that <named-content content-type="genus-species">S. olindensis</named-content> has an extra MPx copy encoded by the cosmomycin biosynthetic gene cluster (BGC), acting in complementarity with the previously studied ABC transporter and UvrA class IIa anthracycline resistance proteins as a possible self-resistance factor during the production of COSD. Since other anthracycline BGCs containing the same genes are described in the literature&#x02014;for example, a cytorhodin BGC (accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/MF773975.1" ext-link-type="uri" assigning-authority="insdc">MF773975.1</ext-link>) and other BGCs listed in Fig. S8&#x02014;our findings can most likely be extended to some anthracycline-producing bacteria.</p><p>The protein encoded by <italic toggle="yes">cosI</italic> belongs to the superfamily of ATP-dependent ABC transporters. The organization of this protein includes two motifs, Walker A and Walker B, providing an ATP-binding site, and contains the unique signature motif in ABC transporters that is located upstream from the Walker B motif. For <named-content content-type="genus-species">S. olindensis</named-content>, it was classified as type I: the transporter system consists of two proteins encoded by independent genes, with CosI (NBD) containing the nucleotide-binding domains (Walker A and Walker B) and CosJ (TMD), the hydrophobic membrane protein, containing six transmembrane (TM) helices (Fig. S1).</p><p>ABC transporters belonging to this class have been so far reported solely in organisms that are producers of several antitumor agents (<xref rid="B25" ref-type="bibr">25</xref>). Daunorubicin and doxorubicin are anthracycline drugs produced by <named-content content-type="genus-species">S. peucetius</named-content>. Two genes (<italic toggle="yes">drrA</italic> and <italic toggle="yes">drrB</italic>) whose products form a type I transporter system have been cloned and found to confer resistance to daunorubicin/doxorubicin and mithramycin (<italic toggle="yes">mtrA</italic> and <italic toggle="yes">mtrB</italic> genes) (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B26" ref-type="bibr">26</xref><xref rid="B27" ref-type="bibr">&#x02013;</xref><xref rid="B29" ref-type="bibr">29</xref>).</p><p>In Gram-positive bacteria, such as actinobacteria, it has been reported that MPx is a novel CysGPx peroxidase family that degrades hydrogen peroxide and alkyl hydroperoxides in the presence of either the thioredoxin/thioredoxin reductase (Trx/TrxR) or mycoredoxin 1/mycothiol/mycothione reductase (Mrx1MSH/Mtr) reducing systems. MPx protects against the damaging effects of ROS induced by multiple stressors, using thioredoxin or related redoxins as reductants (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). The <named-content content-type="genus-species">S. olindensis</named-content> genome has two putative genes that code for peroxidase-type proteins (accession numbers <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> and <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN79115.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN79115.1</ext-link>) and are involved in the general detoxification of H<sub>2</sub>O<sub>2</sub>. The protection is not only related to anthracycline production, in agreement with the results shown in <xref rid="fig5" ref-type="fig">Fig.&#x000a0;5</xref> for the challenge with H<sub>2</sub>O<sub>2</sub>, in which <named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. peucetius</named-content> show a good detoxification response that is not related to any type of response against anthracycline production. Despite <named-content content-type="genus-species">S. olindensis</named-content> possessing two proteins that could cooperate in ROS depuration, the activity against H<sub>2</sub>O<sub>2</sub> almost disappears in the <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> mutant, indicating that this protein is an important scavenger of this peroxide in the cell, while <named-content content-type="genus-species">S. peucetius</named-content> has just one MPx annotated in its genome; however, it is more closely related to <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN79115.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN79115.1</ext-link> (67.82% identity) than to <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> (56.33% identity).</p><p>It is known that anthracyclines produce free radicals that may, in association with ferric compounds, cause oxidative stress (<xref rid="B32" ref-type="bibr">32</xref>). Oxidative stress depends on reactive oxygen species (ROS), which are generated by the action of xenobiotics and because of metabolic processes (<xref rid="B33" ref-type="bibr">33</xref>). The oxidizing power of O<sub>2</sub><sup>.&#x02212;</sup> and H<sub>2</sub>O<sub>2</sub> is harmful to cells. These species can inactivate important metabolic enzymes or alter their catalytic activity. H<sub>2</sub>O<sub>2</sub> can cross the cell membrane and initiate lipid oxidation by deprotonation of fatty acids (<xref rid="B34" ref-type="bibr">34</xref>).</p><p>Biochemical and physiological data lead to the hypothesis that anthracyclines like DOX or, in our case, COSD can cause the formation of free radicals that stimulate lipid peroxidation and alter cellular integrity (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). This hypothesis supports the premise that the oxidative metabolism of the anticancer quinones represents a significant contribution to the cytotoxic effects of these compounds (<xref rid="B37" ref-type="bibr">37</xref>). These species can inactivate important metabolic enzymes, altering their catalytic activity. In the case of H<sub>2</sub>O<sub>2</sub>, it can cross the cell membrane and initiate lipid oxidation by deprotonation of fatty acids (<xref rid="B34" ref-type="bibr">34</xref>), similar to findings reported for DOX during the redox cycle of anthracyclines (<xref rid="B38" ref-type="bibr">38</xref>).</p><p>Interestingly, the study of Westman and collaborators (<xref rid="B39" ref-type="bibr">39</xref>) correlated the biological activity of 7-deoxydoxorubicinolone in prokaryotes and eukaryotes. The authors could show that the levels of expression of catalase, superoxide dismutase, and glutathione peroxidase in bacterial cells are higher than the levels in human cells from cardiac tissue. They concluded that bacterial cells are much more competent at dealing with the outcomes of anthracycline semiquinone oxidation-reduction cycling and the resulting reactive oxygen species (ROS) that evolve and that <named-content content-type="genus-species">Streptomyces</named-content> bacteria are generally well equipped to deal with reactive oxygen stress (<xref rid="B39" ref-type="bibr">39</xref>). The aglycone molecules may accumulate in membranes due to their hydrophobicity; the rapid growth and division of bacterial cells relative to that of eukaryotic cardiac tissue may also explain the differential effects of anthracycline aglycones on prokaryotes and eukaryotes (<xref rid="B39" ref-type="bibr">39</xref>).</p><p>Based on our present findings, we hypothesize that anthracyclines, such as COSD, are determinant in the production of ROS and that the recruitment of additional antioxidant enzymes coded in BGCs, such as <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link>, can increase the self-resistance of antitumor antibiotics with potential cell toxicity. Another line of evidence is that <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> groups with an independent protein cluster in the Pfam <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link> family SSN, wherein all members belong to cosmomycin-like clusters (Fig. S7), which could also indicate that these proteins boost the protection against anthracycline-generated intracellular ROS.</p><p>COSD reportedly binds DNA more tightly than DOX (<xref rid="B40" ref-type="bibr">40</xref>), but it causes less DNA damage than DOX; even so, the levels of apoptosis induced by both drugs in nucleotide excision repair-deficient fibroblasts are similar (<xref rid="B16" ref-type="bibr">16</xref>). CosU is responsible for minimizing the interaction between COSD and DNA, thereby avoiding damage.</p><p>Normally, DNA damage recognition is performed by the protein UvrA, which belongs to the ABC ATPase superfamily. Bacterial UvrA is a dimeric protein, unique among DNA repair enzymes. This feature enables UvrA to detect various DNA lesions by using an indirect readout mechanism. Other proteins, namely, UvrB, UvrC, and UvrD, are components of nucleotide excision repair (NER) and are essential for the survival of almost every living bacterium (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>).</p><p>The protein encoded by the <italic toggle="yes">cosU</italic> gene has a high similarity to UvrA proteins; however, it contains deletions of the UvrB-binding domain and the first zinc finger motif. For this reason, the protein function is not involved in NER and it is classified as a UvrA-like class IIa protein (<xref rid="B43" ref-type="bibr">43</xref>). Proteins of the latter class have been shown to behave <italic toggle="yes">in vitro</italic> like ATP-dependent DNA-binding proteins, such as that of <named-content content-type="genus-species">S. peucetius</named-content> from the daunorubicin cluster (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B15" ref-type="bibr">15</xref>), the nogalamycin produced by <named-content content-type="genus-species">Streptomyces nogalater</named-content> (<xref rid="B44" ref-type="bibr">44</xref>), the product of <italic toggle="yes">cmrX</italic> that confers resistance to chromomycin in <named-content content-type="genus-species">Streptomyces griseus</named-content> subsp. <italic toggle="yes">griseus</italic> (<xref rid="B45" ref-type="bibr">45</xref>), and the product of <italic toggle="yes">mtrX</italic>, which is a UvrA-like protein involved in mithramycin resistance in <named-content content-type="genus-species">Streptomyces argillaceus</named-content> (<xref rid="B46" ref-type="bibr">46</xref>).</p><p>Interestingly, the most common characteristic of these antitumor antibiotics is that they intercalate to DNA and could represent a DNA-binding protein that plays a role in self-resistance, inhibiting or destabilizing the interaction of these drugs with genomic DNA, thus preventing intercalating antibiotics from interfering with cell transcription and/or replication. This suggests in turn that the function of UvrA class IIa proteins is associated with the removal of noncovalent DNA-binding agents.</p><p>Finally, we propose a model (<xref rid="fig7" ref-type="fig">Fig.&#x000a0;7</xref>) for the self-resistance in <named-content content-type="genus-species">S. olindensis</named-content> strain DAUFPE 5622 during cosmomycin D biosynthesis. This compound is recognized by the ABC transporter CosI/CosJ, and then mycothiol peroxidase (CosP) participates in the protection against H<sub>2</sub>O<sub>2</sub> and lipid peroxidation caused by anthracyclines. The UvrA-like protein is important for reducing the interaction between DNA and the antibiotic. This mode of resistance represents an advantage for the producer strain for survival during antibiotic biosynthesis; the organism avoids the interaction of the harmful compound COSD with its intracellular target. <named-content content-type="genus-species">Streptomyces</named-content> evolution developed different strategies of self-resistance, and these depend on the form of action of the active compound. It is important to understand those mechanisms in producer microorganisms to evaluate plausible horizontal transfer in pathogenic strains and to develop therapeutic alternatives.</p><fig position="float" id="fig7"><label>FIG&#x000a0;7</label><caption><p>Proposed model for self-resistance to cosmomycin D in <named-content content-type="genus-species">S. olindensis</named-content>. Mechanisms of self-resistance for COSD: drug efflux function is by CosI and CosJ; CosU protein is involved in DNA repair, scanning the COSD-DNA-binding complex; and CosP (MPx) enzyme is proposed as a new self-resistance mechanism for H<sub>2</sub>O<sub>2</sub> detoxification.</p></caption><graphic xlink:href="spectrum.00493-22-f007" position="anchor"/></fig></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title>Bacterial strains and culture conditions.</title><p>Strains used for cloning or conjugation were <named-content content-type="genus-species">E. coli</named-content> XL11 blue (Agilent technologies) and the methylation-deficient <named-content content-type="genus-species">E. coli</named-content> ET12567/pUZ8002 (<xref rid="B47" ref-type="bibr">47</xref>), respectively. <named-content content-type="genus-species">E. coli</named-content> strains were grown and maintained at 37&#x000b0;C in Luria-Bertani (LB) medium or LB agar (LB with 1.5% agar) supplemented with 30&#x02009;mg/mL chloramphenicol, 50&#x02009;mg/mL kanamycin, and 50&#x02009;mg/mL apramycin, when required.</p><p><named-content content-type="genus-species">Streptomyces</named-content> strains were obtained from stocks of the actinobacteria collection of the pharmaceutical biology department of the University of T&#x000fc;bingen. <named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622 was obtained through G. Padilla from the Institute of Biomedical Sciences of the University of Sao Paulo. <named-content content-type="genus-species">S. peucetius</named-content> DSM 40754 was obtained from the German Collection of Microorganisms and Cell Cultures GmbH (DSMZ).</p><p><named-content content-type="genus-species">Streptomyces</named-content> strains were grown and maintained at 30&#x000b0;C in trypticase soy (TS) broth and/or TS agar (Sigma-Aldrich), mannitol-soy agar (2% mannitol, 2% soybean meal, 10&#x02009;mM MgCl<sub>2</sub>, 1.5% agar), R2YE (<xref rid="B48" ref-type="bibr">48</xref>), and R5M to produce cosmomycin D (<xref rid="B5" ref-type="bibr">5</xref>).</p></sec><sec id="s4-2"><title>Cosmomycin D production, purification, and structure integrity.</title><p>Doxorubicin was obtained from Sigma-Aldrich. Cosmomycin D utilized in this study was isolated and purified from 5-L R5M medium fermentations of <named-content content-type="genus-species">S. olindensis</named-content>, as previously reported (<xref rid="B6" ref-type="bibr">6</xref>).</p><p>For analysis of cosmomycin production, the crude extract was dissolved in methanol (liquid chromatography-mass spectrometry [LC-MS] grade; Merck) and applied to a solid-phase extraction cartridge (Strata-XL, 100&#x02009;&#x003bc;m polymeric reversed phase, 2&#x000a0;g; Phenomenex). The adsorbed compounds were eluted in fractions using a stepwise gradient of 10% to 100% methanol and concentrated under reduced pressure. After resuspension of the residue, 10-&#x003bc;L samples were analyzed by high-performance (HP) LC-MS, using a reverse-phase column (Luna Omega Polar C<sub>18</sub>, 3&#x02009;&#x003bc;m, 150&#x02009;mm by 3.0&#x02009;mm; Phenomenex) and a mobile phase of acetonitrile (solvent A) and 0.06% formic acid in water (solvent B). A gradient of 10% B to 100% B in 22&#x02009;min, ending with 100% B for an additional 8&#x02009;min, with a flow rate of 0.2&#x02009;mL/min was used. The fraction containing COSD (<italic toggle="yes">m/z</italic> 1,189.54) was further purified using a Waters HPLC system (Waters 1525 binary pump with a 7725i Rheodyne injection port, a Kromega solvent degasser and a Waters 996 photodiode array detector), using a linear gradient of 40% B to 60% B in 15&#x02009;min, followed by a linear gradient of 60% B to 95% B in 20&#x02009;min and an additional 10&#x02009;min at 95% B (solvent A, 0.06% formic acid in water; solvent B, 0.1% formic acid in acetonitrile) at a flow rate of 2&#x02009;mL/min (Luna Omega Polar C<sub>18</sub> column, 5&#x02009;&#x003bc;m, 250&#x02009;mm by 4.6&#x02009;mm; Phenomenex) to obtain ~5&#x02009;mg pure COSD.</p><p>For structure determination, high-resolution LC-electrospray ionization (ESI)/MS and MS/MS measurements were performed on a Bruker Daltonics maXis 4G (Bruker Daltonics, Bremen, Germany) connected to a Thermo Scientific UltiMate 3000 system (Thermo Fisher Scientific), using a reversed-phase Luna Omega Polar C<sub>18</sub> column (3&#x02009;&#x003bc;m, 150 by 3&#x02009;mm) at a flow rate of 0.3&#x02009;mL/min. A linear gradient of 10% to 100% solvent B in 40&#x02009;min, ending with 100% B for an additional 15&#x02009;min, was used (solvent A, 0.1% formic acid in water; solvent B, acetonitrile), with an injection volume of 5 &#x003bc;L and UV monitoring occurred at 210, 254, 280, and 360&#x02009;nm. The range of MS acquisition was <italic toggle="yes">m/z</italic> 50 to 1,800. The acquisition parameters for the positive ion polarity were a capillary voltage of 4.5, nebulizer gas pressure (nitrogen) set to 2.0&#x02009;bar, and dry gas flow of 9.0 L/min at an ion source temperature of 200&#x000b0;C. The measurements were internally calibrated using sodium formate as a reference. The data were compared to data of cosmomycin D and to published data of various related compounds (Fig. S9, Table S1) (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B16" ref-type="bibr">16</xref>).</p></sec><sec id="s4-3"><title>DNA isolation and manipulation.</title><p>Plasmid preparation from <named-content content-type="genus-species">E. coli</named-content> was carried out with a commercial kit (QIAprep spin miniprep kit; Qiagen). Total <named-content content-type="genus-species">Streptomyces</named-content> DNA isolation, restriction endonuclease digestions, and ligations were performed as described previously (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>). DNA sequencing was performed at Eurofins Genomics Germany GmbH.</p></sec><sec id="s4-4"><title>Cloning and construction of plasmids for heterologous expression of cosmomycin resistance genes in <named-content content-type="genus-species">S. lividans</named-content> TK24.</title><p><italic toggle="yes">cosI</italic>, <italic toggle="yes">cosJ</italic>, <italic toggle="yes">cosP</italic>, and <italic toggle="yes">cosU</italic> genes were amplified from <named-content content-type="genus-species">S. olindensis</named-content> DAUFPE 5622 genomic DNA using Phusion high-fidelity DNA polymerase from New England Biolabs, Inc., according to the manufacturer&#x02019;s instructions, using the primers listed in Table S3. The resulting PCR products were cloned into the pUWL_Apra-oriT vector containing an apramycin resistance gene cassette under the control of the constitutively active <italic toggle="yes">ermE*</italic> promoter to ensure a high level of expression. These constructs (Table S4) were transferred into <named-content content-type="genus-species">E. coli</named-content> XL1 blue and further into <named-content content-type="genus-species">E. coli</named-content> ET12567/PUZ8002 to obtain nonmethylated DNA. The constructs pRCWL04 (<italic toggle="yes">cosI</italic> and <italic toggle="yes">cosJ</italic>), pRCWL05 (<italic toggle="yes">cosP</italic>), and pRCWL06 (<italic toggle="yes">cosU</italic>) were finally transferred into <named-content content-type="genus-species">S. lividans</named-content> TK24 by conjugation (<xref rid="B50" ref-type="bibr">50</xref>).</p></sec><sec id="s4-5"><title>Expression and purification of recombinant CosP and CosP(C38S) in <named-content content-type="genus-species">E. coli</named-content>.</title><p>For cloning and expression of the mycothiol peroxidase CosP, the IPTG (isopropyl-&#x003b2;-<sc>d</sc>-thiogalactopyranoside)-inducible vector pHIS8 (<xref rid="B51" ref-type="bibr">51</xref>) was used to generate an N-terminally His<sub>8</sub>-tagged CosP. <italic toggle="yes">cosP</italic> was amplified by PCR from genomic DNA (gDNA) of <named-content content-type="genus-species">S. olindensis</named-content> using primers containing recognition sequences for EcoRI and HindIII, respectively. The PCR product was cloned into the expression vector through ligation, taking advantage of the EcoRI<italic toggle="yes">/</italic>HindIII restriction sites, generating plasmid pRCWL04. The integrity of the resulting plasmids was verified via sequencing.</p><p>Plasmid pRCWL04 was further modified in the CALA coding region of the enzyme (MPx), exchanging cysteine (C) for serine (S) at position 38, using the QuikChange II site-directed mutagenesis kit (Agilent Technologies), resulting in plasmid pRCWL04M.</p><p>Heterologous expression and purification of His<sub>8</sub>-tagged proteins were carried out using <named-content content-type="genus-species">E. coli</named-content> Rosetta 2(DE3)pLys (Novagen, Darmstadt, Germany) as the recombinant host strain. Strains containing the corresponding plasmid were cultivated in 1 L LB broth supplemented with 25&#x02009;&#x003bc;g/mL chloramphenicol and 50&#x02009;&#x003bc;g/mL kanamycin at 37&#x000b0;C and 220&#x02009;rpm. At an optical density at 600&#x000a0;nm (OD<sub>600</sub>) of 0.6, the temperature was adjusted to 18&#x000b0;C and IPTG was added to a final concentration of 0.5&#x02009;mM.</p><p>The overnight culture was harvested by centrifugation at 8,000&#x02009;rpm and 4&#x000b0;C for 10&#x02009;min. The supernatant was discarded, and the pellet resuspended in lysis buffer (3&#x02009;mL/g pellet) (50&#x02009;mM Tris-HCl, pH 8, 500&#x02009;mM NaCl, 10% glycerin [vol/vol], 1% Tween 20 [vol/vol], 20&#x02009;mM imidazole, 10&#x02009;mM &#x003b2;-mercaptoethanol, 0.5&#x02009;mg/mL lysozyme, 0.5&#x02009;mM phenylmethylsulfonyl fluoride [PMSF], and 4&#x02009;mg/mL lysozyme). The cells were sonicated (Sonifier generator; Branson) on ice for 10&#x02009;min (amplitude of 40%, 5&#x000a0;s on/5&#x000a0;s off). After centrifugation for 45&#x02009;min at 18,000&#x02009;rpm (4&#x000b0;C), the clear lysate was filtered (0.45&#x02009;&#x003bc;m) for affinity chromatography.</p><p>Supernatant of each culture was applied to affinity chromatography using an &#x000c4;kta start platform (GE Healthcare) equipped with a 5-mL His-Trap HP column (GE Healthcare). The His-tagged protein was washed and then eluted from the column using a linear gradient of 0 to 100% elution buffer over 60&#x02009;min and collected by a Frac30 system (GE Healthcare). Fractions were tested for the presence of the respective proteins by SDS-PAGE and were concentrated and buffer exchanged into 25&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>,100&#x02009;mM NaCl, pH 8.3, using an Amicon Ultra centrifugal filter (<italic toggle="yes">M</italic><sub>r</sub> cutoff of 10,000; Millipore). Concentrations of the purified proteins were measured spectrophotometrically at 280&#x02009;nm using the calculated extinction coefficients (calculated with <ext-link xlink:href="http://web.expasy.org/protparam/" ext-link-type="uri">http://web.expasy.org/protparam/</ext-link>). The purified proteins were stored in aliquots at &#x02212;80&#x000b0;C.</p></sec><sec id="s4-6"><title>Purification of total protein from <italic toggle="yes">Streptomyces</italic> strains.</title><p><named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. lividans</named-content> pUWL (apramycin) were incubated in 100&#x02009;mL TS broth for 48 h at 30&#x000b0;C at 220&#x02009;rpm. Five&#x02009;milliliters of the preculture was added to 100&#x02009;mL of YEME (<xref rid="B48" ref-type="bibr">48</xref>) medium and incubated for a further 2&#x02009;days at 30&#x000b0;C at 220&#x02009;rpm. The cultures were stored on ice for 20&#x02009;min and then centrifuged at 6,000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 30&#x02009;min at 4&#x000b0;C. The supernatant was discarded, and the pellet resuspended in lysis buffer (5&#x02009;mL/g pellet) (50&#x02009;mM Tris-HCl, pH 8, 500&#x02009;mM NaCl, 10% glycerin [vol/vol], 1% Tween 20 [vol/vol], 20&#x02009;mM imidazole, 10&#x02009;mM &#x003b2;-mercaptoethanol, 0.5&#x02009;mM PMSF, and 4&#x02009;mg/mL lysozyme). The cells were ruptured with a French press under 10,000 lb/in<sup>2</sup> pressure, and cell debris was removed by centrifugation at 4&#x000b0;C for 45&#x02009;min at 15,000&#x02009;rpm. The clear lysate was filtered (0.45&#x02009;&#x003bc;m) for buffer exchange (25&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 100&#x02009;mM NaCl, pH 8.3). The purified proteins were quantified and stored at the same concentration at &#x02212;80&#x000b0;C.</p></sec><sec id="s4-7"><title>Peroxide and protein quantification.</title><p>The concentration of H<sub>2</sub>O<sub>2</sub> stock solution (Sigma-Aldrich) was measured at 240&#x02009;nm (&#x003b5;240&#x000a0;nm&#x02009;=&#x02009;43.6 M<sup>&#x02212;1</sup>&#x02009;cm<sup>&#x02212;1</sup>) (<xref rid="B52" ref-type="bibr">52</xref>). Protein concentrations were determined spectrophotometrically at 280&#x02009;nm; the molar absorption coefficients were calculated from the amino acid compositions (<ext-link xlink:href="http://web.expasy.org/protparam/" ext-link-type="uri">http://web.expasy.org/protparam/</ext-link>) (<xref rid="B53" ref-type="bibr">53</xref>). The calculated protein concentrations refer to those of monomers.</p></sec><sec id="s4-8"><title>FOX assay.</title><p>WT MPx and its mutant were reduced with 10&#x000d7; excess dithiothreitol (DTT) in buffer solution (250&#x02009;mM Tris buffer, 500&#x02009;mM NaCl, pH 8.0) and incubated for 30&#x02009;min at room temperature. The ferrous oxidation of xylenol orange (FOX) assay (<xref rid="B54" ref-type="bibr">54</xref>) was used to determine the H<sub>2</sub>O<sub>2</sub> consumption over time by the purified MPx or the C38S mutant and total proteins from <named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. peucetius</named-content> strains isolated during antibiotic production. All measurements were performed in three replicates for each treatment. The H<sub>2</sub>O<sub>2</sub> concentration was calculated based on an H<sub>2</sub>O<sub>2</sub> standard curve. In the case of purified MPx and mutant MPx, 100&#x02009;&#x003bc;M was mixed with 100&#x02009;&#x003bc;M H<sub>2</sub>O<sub>2</sub> in 100&#x02009;mM assay buffer, pH 8, at 30&#x000b0;C, and 10-&#x003bc;L amounts of the reaction mixture were taken after 15, 30, 45, 90, and 180&#x02009;s and mixed with 490&#x02009;&#x003bc;L of the FOX reaction mixture (100&#x02009;&#x003bc;M xylenol orange, 250&#x02009;&#x003bc;M ammonium ferrous sulfate, 100&#x02009;mM sorbitol, and 25&#x02009;mM H<sub>2</sub>SO<sub>4</sub>) and incubated for 30&#x02009;min at room temperature in darkness. At the end of the reaction, the <italic toggle="yes">A</italic><sub>560</sub> was measured on a 96-well plate reader (FLUOstar Omega) as described elsewhere (<xref rid="B54" ref-type="bibr">54</xref>). To isolate total proteins from <named-content content-type="genus-species">S. olindensis</named-content> and <named-content content-type="genus-species">S. lividans</named-content>, cells were initially grown in TS broth at 30&#x000b0;C for 24 h. One percent preculture was used to inoculate the main R5M culture. This culture was grown at 30&#x000b0;C for protein extraction at 24, 48, and 72&#x02009;h during the production of cosmomycin D for <named-content content-type="genus-species">S. olindensis</named-content>. Then, 100&#x02009;mM H<sub>2</sub>O<sub>2</sub> was added to equal concentrations of total proteins. Ten-microliter aliquots were taken after 100, 200, 300, 400, 500, and 600&#x02009;s, as described elsewhere (<xref rid="B54" ref-type="bibr">54</xref>).</p></sec><sec id="s4-9"><title>Total RNA isolation and cDNA synthesis.</title><p>Total RNA of producer strain <named-content content-type="genus-species">S. olindensis</named-content> WT was extracted using RNAprotect bacterial reagent and the RNeasy minikit according to the manufacturer&#x02019;s instructions (Qiagen). The frozen samples were ground in dry ice. Residual DNA was removed by treating with RNase-free DNase according to the manufacturer&#x02019;s instructions (Qiagen). An aliquot of 1&#x02009;&#x003bc;g of DNase-treated RNA was transcribed into cDNA using iScript reverse transcription supermix for reverse transcription (RT)-qPCR (Bio-Rad Laboratories, Inc.).</p></sec><sec id="s4-10"><title>qPCR analysis.</title><p>For qPCR, a Bio-Rad iQ5 thermocycler (Bio-Rad Laboratories, Inc.) was programmed for an initial denaturation of 5&#x02009;min at 95&#x000b0;C, followed by 40 cycles of 5&#x000a0;s at 95&#x000b0;C and 15&#x000a0;s at 60&#x000b0;C. The specificity of the qPCR primers (Table S3) was evaluated by the melting curve, using a gradient of 55 to 95&#x000b0;C at 1&#x000b0;C each 30&#x000a0;s (Fig. S10). For each amplification reaction mixture volume, 2&#x02009;&#x003bc;L of cDNA (50&#x02009;ng), 10 &#x003bc;M each primer, and 10&#x02009;&#x003bc;L of QuantiNova probe PCR kit (Qiagen) were used.</p><p>iQ5 Optical System software was used to determine the relative quantification of the target genes in comparison to the reference gene. The selection of an endogenous gene, to be used as a normalizer, was made by testing the cycle threshold (<italic toggle="yes">C<sub>T</sub></italic>) values for the different described endogenous genes (Fig. S10). The <italic toggle="yes">hdrB</italic> housekeeping gene presented the lowest &#x00394;<italic toggle="yes">C<sub>T</sub></italic> and the highest amplification efficiency, resulting in its selection as the normalizer for gene expression analysis.</p></sec><sec id="s4-11"><title>Determination of MICs of anthracyclines.</title><p>Sterile 96-well plates were used to generate MIC values. Each well contained 100&#x02009;&#x003bc;L of Bennett&#x02019;s agar and doxorubicin or cosmomycin D with concentrations ranging from 0 to 512&#x02009;&#x003bc;g/mL. Each well was inoculated with ~10<sup>3</sup>
<named-content content-type="genus-species">Streptomyces</named-content> spores. Plates were incubated overnight at 30&#x000b0;C. Growth was compared with that of the controls, <named-content content-type="genus-species">S. peucetius</named-content>, <named-content content-type="genus-species">S. olindensis</named-content>, and <named-content content-type="genus-species">S. lividans</named-content> TK24/pUWL (empty vector).</p></sec><sec id="s4-12"><title>Construction of SSNs and GNN.</title><p>Web tools of the Enzyme Function Initiative (EFI), available at <ext-link xlink:href="https://efi.igb.illinois.edu/" ext-link-type="uri">https://efi.igb.illinois.edu/</ext-link> (<xref rid="B22" ref-type="bibr">22</xref>), were used to generated sequence similarity networks (SSNs) from <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> and the glutathione peroxidase Pfam family (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link>). For the seed SSN obtained with the <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/KDN80073.1" ext-link-type="uri" assigning-authority="ncbiprotein">KDN80073.1</ext-link> FASTA sequence, the option Maximum Number of Retrieve Sequences&#x02009;=&#x02009;100 in the BLAST Retrieval Options tab was selected, and then the score threshold was adjusted to 65 using Percent Identity vs Alignment Score Box Plot in order to set up only the presence of nodes with identity equal to 70% or above.</p><p>For the initial submission of <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/PF00255" ext-link-type="uri" assigning-authority="insdc">PF00255</ext-link>, all settings were kept at the default, and a first SSN was generated using a Score threshold of 50, which means each edge joins nodes with at least 55% similarity. The second SSN used a slightly higher score threshold of 60 (nodes are joined if they share about 61% or more identity). Using the EFI Genome Neighborhood Tool (EFI-GNT tab) of the same website, a genome neighborhood network (GNN) and genome neighborhood diagrams (GNDs) of the second SSN were obtained using as parameters Neighborhood Size&#x02009;=&#x02009;20 and Cooccurrence Percentage Lower Limit&#x02009;=&#x02009;20.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We thank DAAD (Deutscher Akademisher Austauschdienst) for the doctoral fellowship to R.D.A.C. (Grant 57299294). Financial support from FAPESP (Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo) to G.P. (Grant 09/52664-4).</p><p>We thank Dorothee Wistuba (Organic Chemistry, University of T&#x000fc;bingen) for HR-MS measurements and Tobias Dick for assistance in the FOX assays.</p></ack><fn-group><fn fn-type="other"><p>
<italic toggle="yes">[This article was published on 5 May 2022 with errors in the ordering of the supplemental material. The supplemental material was updated in the current version, posted on 17 May 2022.]</italic>
</p></fn><fn fn-type="supplementary-material"><p>Supplemental material is available online only.</p><p>
<supplementary-material id="SuF1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/spectrum.00493-22.1</object-id><label>SUPPLEMENTAL FILE 1</label><caption><p>Supplemental material. Download <inline-supplementary-material id="SF1" xlink:href="spectrum.00493-22-s001.pdf" content-type="local-data">spectrum.00493-22-s001.pdf, PDF file, 7.2 MB</inline-supplementary-material></p></caption></supplementary-material></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arcamone</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cassinelli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Fantini</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Grein</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Orezzi</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pol</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Spalla</surname>
<given-names>C</given-names></string-name></person-group>. <year>1969</year>. <article-title>Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius</article-title>. <source>Biotechnol Bioeng</source>
<volume>11</volume>:<fpage>1101</fpage>&#x02013;<lpage>1110</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bit.260110607</pub-id>.<pub-id pub-id-type="pmid">5365804</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Binaschi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bigioni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cipollone</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rossi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Goso</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Maggi</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Capranico</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Animati</surname>
<given-names>F</given-names></string-name></person-group>. <year>2001</year>. <article-title>Anthracyclines: selected new developments</article-title>. <source>Curr Med Chem Anticancer Agents</source>
<volume>1</volume>:<fpage>113</fpage>&#x02013;<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1568011013354723</pub-id>.<pub-id pub-id-type="pmid">12678762</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Minotti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Menna</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Salvatorelli</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cairo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gianni</surname>
<given-names>L</given-names></string-name></person-group>. <year>2004</year>. <article-title>Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity</article-title>. <source>Pharmacol Rev</source>
<volume>56</volume>:<fpage>185</fpage>&#x02013;<lpage>229</lpage>. doi:<pub-id pub-id-type="doi">10.1124/pr.56.2.6</pub-id>.<pub-id pub-id-type="pmid">15169927</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lorusso</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Manzione</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Silvestris</surname>
<given-names>N</given-names></string-name></person-group>. <year>2007</year>. <article-title>Role of liposomal anthracyclines in breast cancer</article-title>. <source>Ann Oncol</source>
<volume>18</volume>:<fpage>vi70</fpage>&#x02013;<lpage>vi73</lpage>. doi:<pub-id pub-id-type="doi">10.1093/annonc/mdm229</pub-id>.<pub-id pub-id-type="pmid">17591837</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Furlan</surname>
<given-names>RLA</given-names></string-name>, <string-name><surname>Watt</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Garrido</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Amarante-Mendes</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Nur-e-Alam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rohr</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bra&#x000f1;a</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mendez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Sheil</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Beck</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Padilla</surname>
<given-names>G</given-names></string-name></person-group>. <year>2004</year>. <article-title>DNA-binding properties of cosmomycin D, an anthracycline with two trisaccharide chains</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>57</volume>:<fpage>647</fpage>&#x02013;<lpage>654</lpage>. doi:<pub-id pub-id-type="doi">10.7164/antibiotics.57.647</pub-id>.<pub-id pub-id-type="pmid">15638325</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garrido</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Lomb&#x000f3;</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Baig</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Nur-E-Alam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Furlan</surname>
<given-names>RLA</given-names></string-name>, <string-name><surname>Borda</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Bra&#x000f1;a</surname>
<given-names>A</given-names></string-name>, <string-name><surname>M&#x000e9;ndez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Rohr</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Padilla</surname>
<given-names>G</given-names></string-name></person-group>. <year>2006</year>. <article-title>Insights in the glycosylation steps during biosynthesis of the antitumor anthracycline cosmomycin: characterization of two glycosyltransferase genes</article-title>. <source>Appl Microbiol Biotechnol</source>
<volume>73</volume>:<fpage>122</fpage>&#x02013;<lpage>131</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00253-006-0453-z</pub-id>.<pub-id pub-id-type="pmid">16810496</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miyamoto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Johdo</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Nagamatsu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yoshimoto</surname>
<given-names>A</given-names></string-name></person-group>. <year>2002</year>. <article-title>Cloning and characterization of a glycosyltransferase gene involved in the biosynthesis of anthracycline antibiotic &#x003b2;-rhodomycin from Streptomyces violaceus</article-title>. <source>FEMS Microbiol Lett</source>
<volume>206</volume>:<fpage>163</fpage>&#x02013;<lpage>168</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.2002.tb11003.x</pub-id>.<pub-id pub-id-type="pmid">11814657</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hopwood</surname>
<given-names>DA</given-names></string-name></person-group>. <year>2007</year>. <article-title>How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them?</article-title>
<source>Mol Microbiol</source>
<volume>63</volume>:<fpage>937</fpage>&#x02013;<lpage>940</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05584.x</pub-id>.<pub-id pub-id-type="pmid">17238916</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sugiyama</surname>
<given-names>M</given-names></string-name></person-group>. <year>2015</year>. <article-title>Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>68</volume>:<fpage>543</fpage>&#x02013;<lpage>548</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ja.2015.32</pub-id>.<pub-id pub-id-type="pmid">25873321</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lomovskaya</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hong</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>SU</given-names></string-name>, <string-name><surname>Fonstein</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Furuya</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hutchinson</surname>
<given-names>RC</given-names></string-name></person-group>. <year>1996</year>. <article-title>The Streptomyces peucetius drrC gene encodes a UvrA-like protein involved in daunorubicin resistance and production</article-title>. <source>J Bacteriol</source>
<volume>178</volume>:<fpage>3238</fpage>&#x02013;<lpage>3245</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.178.11.3238-3245.1996</pub-id>.<pub-id pub-id-type="pmid">8655504</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sugiyama</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nimi</surname>
<given-names>O</given-names></string-name></person-group>. <year>1990</year>. <article-title>Streptomycin: biosynthesis and self-resistance mechanism in streptomycin-producing <italic toggle="yes">Streptomyces griseus</italic></article-title>. <source>Actinomycetologica</source>
<volume>4</volume>:<fpage>15</fpage>&#x02013;<lpage>22</lpage>. doi:<pub-id pub-id-type="doi">10.3209/saj.4_15</pub-id>.</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guilfoile</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Hutchinson</surname>
<given-names>CR</given-names></string-name></person-group>. <year>1991</year>. <article-title>A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>88</volume>:<fpage>8553</fpage>&#x02013;<lpage>8557</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.88.19.8553</pub-id>.<pub-id pub-id-type="pmid">1924314</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Malla</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Niraula</surname>
<given-names>NP</given-names></string-name>, <string-name><surname>Liou</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sohng</surname>
<given-names>JK</given-names></string-name></person-group>. <year>2010</year>. <article-title>Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement</article-title>. <source>Microbiol Res</source>
<volume>165</volume>:<fpage>259</fpage>&#x02013;<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micres.2009.04.002</pub-id>.<pub-id pub-id-type="pmid">19651502</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Srinivasan</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Palani</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Prasad</surname>
<given-names>R</given-names></string-name></person-group>. <year>2010</year>. <article-title>Daunorubicin efflux in Streptomyces peucetius modulates biosynthesis by feedback regulation</article-title>. <source>FEMS Microbiol Lett</source>
<volume>305</volume>:<fpage>18</fpage>&#x02013;<lpage>27</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.2010.01905.x</pub-id>.<pub-id pub-id-type="pmid">20158521</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Furuya</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hutchinson</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Richard Hutchinson</surname>
<given-names>C</given-names></string-name></person-group>. <year>1998</year>. <article-title>The DrrC protein of Streptomyces peucetius, a UvrA-like protein, is a DNA-binding protein whose gene is induced by daunorubicin</article-title>. <source>FEMS Microbiol Lett</source>
<volume>168</volume>:<fpage>243</fpage>&#x02013;<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.1998.tb13280.x</pub-id>.<pub-id pub-id-type="pmid">9835035</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carvalho</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Garrido</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Furlan</surname>
<given-names>RLA</given-names></string-name>, <string-name><surname>Padilla</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Agnoletto</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Guecheva</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Henriques</surname>
<given-names>JAP</given-names></string-name>, <string-name><surname>Saffi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Menck</surname>
<given-names>CFM</given-names></string-name></person-group>. <year>2010</year>. <article-title>DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells</article-title>. <source>Cancer Chemother Pharmacol</source>
<volume>65</volume>:<fpage>989</fpage>&#x02013;<lpage>994</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00280-010-1244-x</pub-id>.<pub-id pub-id-type="pmid">20107801</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pedre</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Van Molle</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Villadangos</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Wahni</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Vertommen</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Turell</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Erdogan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mateos</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Messens</surname>
<given-names>J</given-names></string-name></person-group>. <year>2015</year>. <article-title>The Corynebacterium glutamicum mycothiol peroxidase is a reactive oxygen species-scavenging enzyme that shows promiscuity in thiol redox control</article-title>. <source>Mol Microbiol</source>
<volume>96</volume>:<fpage>1176</fpage>&#x02013;<lpage>1191</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.12998</pub-id>.<pub-id pub-id-type="pmid">25766783</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bouige</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Laurent</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Piloyan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dassa</surname>
<given-names>E</given-names></string-name></person-group>. <year>2002</year>. <article-title>Phylogenetic and functional classification of ATP-binding cassette (ABC) systems</article-title>. <source>Curr Protein Pept Sci</source>
<volume>3</volume>:<fpage>541</fpage>&#x02013;<lpage>559</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1389203023380486</pub-id>.<pub-id pub-id-type="pmid">12370001</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Rahman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kaur</surname>
<given-names>P</given-names></string-name></person-group>. <year>2015</year>. <article-title>Characterization of a novel domain &#x0201c;GATE&#x0201d; in the ABC protein DrrA and its role in drug efflux by the DrrAB complex</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>459</volume>:<fpage>148</fpage>&#x02013;<lpage>153</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbrc.2015.02.086</pub-id>.<pub-id pub-id-type="pmid">25721665</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Higgins</surname>
<given-names>CF</given-names></string-name></person-group>. <year>2001</year>. <article-title>ABC transporters: physiology, structure and mechanism&#x02014;an overview</article-title>. <source>Res Microbiol</source>
<volume>152</volume>:<fpage>205</fpage>&#x02013;<lpage>210</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0923-2508(01)01193-7</pub-id>.<pub-id pub-id-type="pmid">11421269</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holland</surname>
<given-names>IB</given-names></string-name></person-group>. <year>2011</year>. <article-title>ABC transporters, mechanisms and biology: an overview</article-title>. <source>Essays Biochem</source>
<volume>50</volume>:<fpage>1</fpage>&#x02013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bse0500001</pub-id>.<pub-id pub-id-type="pmid">21967049</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zallot</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Oberg</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Gerlt</surname>
<given-names>JA</given-names></string-name></person-group>. <year>2019</year>. <article-title>The EFI Web Resource for Genomic Enzymology Tools: leveraging protein, genome, and metagenome databases to discover novel enzymes and metabolic pathways</article-title>. <source>Biochemistry</source>
<volume>58</volume>:<fpage>4169</fpage>&#x02013;<lpage>4182</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.biochem.9b00735</pub-id>.<pub-id pub-id-type="pmid">31553576</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prija</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Prasad</surname>
<given-names>R</given-names></string-name></person-group>. <year>2017</year>. <article-title>DrrC protein of Streptomyces peucetius removes daunorubicin from intercalated dnrI promoter</article-title>. <source>Microbiol Res</source>
<volume>202</volume>:<fpage>30</fpage>&#x02013;<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.micres.2017.05.002</pub-id>.<pub-id pub-id-type="pmid">28647120</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>&#x00160;m&#x000ed;dov&#x000e1;</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zikov&#x000e1;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Posp&#x000ed;&#x00161;il</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schwarz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bobek</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vohradsky</surname>
<given-names>J</given-names></string-name></person-group>. <year>2019</year>. <article-title>DNA mapping and kinetic modeling of the HrdB regulon in Streptomyces coelicolor</article-title>. <source>Nucleic Acids Res</source>
<volume>47</volume>:<fpage>621</fpage>&#x02013;<lpage>633</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gky1018</pub-id>.<pub-id pub-id-type="pmid">30371884</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>M&#x000e9;ndez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>JA</given-names></string-name></person-group>. <year>2001</year>. <article-title>The role of ABC transporters in antibiotic-producing organisms: drug secretion and resistance mechanisms</article-title>. <source>Res Microbiol</source>
<volume>152</volume>:<fpage>341</fpage>&#x02013;<lpage>350</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0923-2508(01)01205-0</pub-id>.<pub-id pub-id-type="pmid">11421281</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fern&#x000e1;ndez</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lomb&#x000f3;</surname>
<given-names>F</given-names></string-name>, <string-name><surname>M&#x000e9;ndez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>JA</given-names></string-name></person-group>. <year>1996</year>. <article-title>An ABC transporter is essential for resistance to the antitumor agent mithramycin in the producer Streptomyces argillaceus</article-title>. <source>Mol Gen Genet</source>
<volume>251</volume>:<fpage>692</fpage>&#x02013;<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF02174118</pub-id>.<pub-id pub-id-type="pmid">8757400</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gandlur</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Levine</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kaur</surname>
<given-names>P</given-names></string-name></person-group>. <year>2004</year>. <article-title>Membrane topology of the DrrB protein of the doxorubicin transporter of Streptomyces peucetius</article-title>. <source>J Biol Chem</source>
<volume>279</volume>:<fpage>27799</fpage>&#x02013;<lpage>27806</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M402898200</pub-id>.<pub-id pub-id-type="pmid">15090538</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaur</surname>
<given-names>P</given-names></string-name></person-group>. <year>1997</year>. <article-title>Expression and characterization of DrrA and DrrB proteins of Streptomyces peucetius in Escherichia coli: DrrA is an ATP binding protein</article-title>. <source>J Bacteriol</source>
<volume>179</volume>:<fpage>569</fpage>&#x02013;<lpage>575</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.179.3.569-575.1997</pub-id>.<pub-id pub-id-type="pmid">9006006</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaur</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>J</given-names></string-name></person-group>. <year>1998</year>. <article-title>Biochemical coupling between the DrrA and DrrB proteins of the doxorubicin efflux pump of Streptomyces peucetius</article-title>. <source>J Biol Chem</source>
<volume>273</volume>:<fpage>17933</fpage>&#x02013;<lpage>17939</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.273.28.17933</pub-id>.<pub-id pub-id-type="pmid">9651400</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flohe</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Toppo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cozza</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ursini</surname>
<given-names>F</given-names></string-name></person-group>. <year>2011</year>. <article-title>A comparison of thiol peroxidase mechanisms</article-title>. <source>Antioxid Redox Signal</source>
<volume>15</volume>:<fpage>763</fpage>&#x02013;<lpage>780</lpage>. doi:<pub-id pub-id-type="doi">10.1089/ars.2010.3397</pub-id>.<pub-id pub-id-type="pmid">20649470</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Si</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Guan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>S-J</given-names></string-name></person-group>. <year>2015</year>. <article-title>Functional characterization of a mycothiol peroxidase in Corynebacterium glutamicum that uses both mycoredoxin and thioredoxin reducing systems in the response to oxidative stress</article-title>. <source>Biochem J</source>
<volume>469</volume>:<fpage>45</fpage>&#x02013;<lpage>57</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20141080</pub-id>.<pub-id pub-id-type="pmid">25891483</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruggiero</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ridola</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Puma</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Molinari</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Coccia</surname>
<given-names>P</given-names></string-name>, <string-name><surname>De Rosa</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Riccardi</surname>
<given-names>R</given-names></string-name></person-group>. <year>2008</year>. <article-title>Anthracycline cardiotoxicity in childhood</article-title>. <source>Pediatr Hematol Oncol</source>
<volume>25</volume>:<fpage>261</fpage>&#x02013;<lpage>281</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08880010802016649</pub-id>.<pub-id pub-id-type="pmid">18484471</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Findlay</surname>
<given-names>VJ</given-names></string-name>, <string-name><surname>Tapiero</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Townsend</surname>
<given-names>DM</given-names></string-name></person-group>. <year>2005</year>. <article-title>Sulfiredoxin: a potential therapeutic agent?</article-title>
<source>Biomed Pharmacother</source>
<volume>59</volume>:<fpage>374</fpage>&#x02013;<lpage>379</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopha.2005.07.003</pub-id>.<pub-id pub-id-type="pmid">16102934</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gechev</surname>
<given-names>TS</given-names></string-name>, <string-name><surname>van Breusegem</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Denev</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Laloi</surname>
<given-names>C</given-names></string-name></person-group>. <year>2006</year>. <article-title>Reactive oxygen species as signals that modulate plant stress responses and programmed cell death</article-title>. <source>Bioessays</source>
<volume>28</volume>:<fpage>1091</fpage>&#x02013;<lpage>1101</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bies.20493</pub-id>.<pub-id pub-id-type="pmid">17041898</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Misiti</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Giardina</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mordente</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Clementi</surname>
<given-names>ME</given-names></string-name></person-group>. <year>2003</year>. <article-title>The secondary alcohol and aglycone metabolites of doxurubicin alter metabolism of human erythrocytes</article-title>. <source>Braz J Med Biol Res</source>
<volume>36</volume>:<fpage>1643</fpage>&#x02013;<lpage>1651</lpage>. doi:<pub-id pub-id-type="doi">10.1590/s0100-879x2003001200005</pub-id>.<pub-id pub-id-type="pmid">14666248</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Powis</surname>
<given-names>G</given-names></string-name></person-group>. <year>1989</year>. <article-title>Free radical formation by antitumor quinones</article-title>. <source>Free Radic Biol Med</source>
<volume>6</volume>:<fpage>63</fpage>&#x02013;<lpage>101</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0891-5849(89)90162-7</pub-id>.<pub-id pub-id-type="pmid">2492250</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doroshow</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Akman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>FF</given-names></string-name>, <string-name><surname>Esworthy</surname>
<given-names>S</given-names></string-name></person-group>. <year>1990</year>. <article-title>Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones</article-title>. <source>Pharmacol Ther</source>
<volume>47</volume>:<fpage>359</fpage>&#x02013;<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0163-7258(90)90062-7</pub-id>.<pub-id pub-id-type="pmid">2290853</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Henderson</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Metz</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>Balcerzak</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Sagone</surname>
<given-names>AL</given-names></string-name></person-group>. <year>1978</year>. <article-title>Adriamycin and daunomycin generate reactive oxygen compounds in erythrocytes</article-title>. <source>Blood</source>
<volume>52</volume>:<fpage>878</fpage>&#x02013;<lpage>885</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood.V52.5.878.878</pub-id>.<pub-id pub-id-type="pmid">698394</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Westman</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Canova</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Radhi</surname>
<given-names>IJ</given-names></string-name>, <string-name><surname>Koteva</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kireeva</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Waglechner</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>GD</given-names></string-name></person-group>. <year>2012</year>. <article-title>Bacterial inactivation of the anticancer drug doxorubicin</article-title>. <source>Chem Biol</source>
<volume>19</volume>:<fpage>1255</fpage>&#x02013;<lpage>1264</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chembiol.2012.08.011</pub-id>.<pub-id pub-id-type="pmid">23102220</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kelso</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rojas</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Furlan</surname>
<given-names>RLA</given-names></string-name>, <string-name><surname>Padilla</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Beck</surname>
<given-names>JL</given-names></string-name></person-group>. <year>2009</year>. <article-title>Characterisation of anthracyclines from a cosmomycin D-producing species of Streptomyces by collisionally-activated dissociation and ion mobility mass spectrometry</article-title>. <source>Eur J Mass Spectrom (Chichester)</source>
<volume>15</volume>:<fpage>73</fpage>&#x02013;<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1255/ejms.948</pub-id>.<pub-id pub-id-type="pmid">19423894</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jaciuk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nowak</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Skowronek</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ta&#x00144;ska</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nowotny</surname>
<given-names>M</given-names></string-name></person-group>. <year>2011</year>. <article-title>Structure of UvrA nucleotide excision repair protein in complex with modified DNA</article-title>. <source>Nat Struct Mol Biol</source>
<volume>18</volume>:<fpage>191</fpage>&#x02013;<lpage>197</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nsmb.1973</pub-id>.<pub-id pub-id-type="pmid">21240268</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Truglio</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Croteau</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>van Houten</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kisker</surname>
<given-names>C</given-names></string-name></person-group>. <year>2006</year>. <article-title>Prokaryotic nucleotide excision repair: the UvrABC system</article-title>. <source>Chem Rev</source>
<volume>106</volume>:<fpage>233</fpage>&#x02013;<lpage>252</lpage>. doi:<pub-id pub-id-type="doi">10.1021/cr040471u</pub-id>.<pub-id pub-id-type="pmid">16464004</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marsza&#x00142;kowska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bil</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kreft</surname>
<given-names>&#x00141;</given-names></string-name>, <string-name><surname>Olszewski</surname>
<given-names>M</given-names></string-name></person-group>. <year>2013</year>. <article-title>A new division of bacterial UvrA homologues</article-title>. <source>BioTechnologia</source>
<volume>94</volume>:<fpage>54</fpage>&#x02013;<lpage>56</lpage>. doi:<pub-id pub-id-type="doi">10.5114/bta.2013.46439</pub-id>.</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torkkell</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kunnari</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Palmu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hakala</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ylihonko</surname>
<given-names>K</given-names></string-name></person-group>. <year>2001</year>. <article-title>The entire nogalamycin biosynthetic gene cluster of Streptomyces nogalater: characterization of a 20-kb DNA region and generation of hybrid structures</article-title>. <source>Mol Genet Genomics</source>
<volume>266</volume>:<fpage>276</fpage>&#x02013;<lpage>288</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s004380100554</pub-id>.<pub-id pub-id-type="pmid">11683270</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Men&#x000e9;ndez</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bra&#x000f1;a</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>M&#x000e9;ndez</surname>
<given-names>C</given-names></string-name></person-group>. <year>2007</year>. <article-title>Involvement of a chromomycin ABC transporter system in secretion of a deacetylated precursor during chromomycin biosynthesis</article-title>. <source>Microbiology (Reading)</source>
<volume>153</volume>:<fpage>3061</fpage>&#x02013;<lpage>3070</lpage>. doi:<pub-id pub-id-type="doi">10.1099/mic.0.2007/007922-0</pub-id>.<pub-id pub-id-type="pmid">17768249</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garcia-Bernardo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bra&#x000f1;a</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>M&#x000e9;ndez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Salas</surname>
<given-names>JA</given-names></string-name></person-group>. <year>2000</year>. <article-title>Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceus</article-title>. <source>FEMS Microbiol Lett</source>
<volume>186</volume>:<fpage>61</fpage>&#x02013;<lpage>65</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1574-6968.2000.tb09082.x</pub-id>.<pub-id pub-id-type="pmid">10779713</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacNeil</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Gewain</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Ruby</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Dezeny</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gibbons</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>MacNeil</surname>
<given-names>T</given-names></string-name></person-group>. <year>1992</year>. <article-title>Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector</article-title>. <source>Gene</source>
<volume>111</volume>:<fpage>61</fpage>&#x02013;<lpage>68</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0378-1119(92)90603-m</pub-id>.<pub-id pub-id-type="pmid">1547955</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Kieser</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Bibb</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Buttner</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Chater</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Hopwood</surname>
<given-names>DA</given-names></string-name></person-group> (ed). <year>2000</year>. <source>Practical Streptomyces genetics.</source>
<publisher-name>John Innes Foundation</publisher-name>, <publisher-loc>Norwich Research Park, Norwich, United Kingdom</publisher-loc>.</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Sambrook</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Russell</surname>
<given-names>DW</given-names></string-name></person-group>. <year>2001</year>. <source>Molecular cloning: a laboratory manual</source>, <edition>3rd ed</edition>. <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>. <comment>ISBN 978-087969577-4</comment>.</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gust</surname>
<given-names>B</given-names></string-name></person-group>. <year>2009</year>. <article-title>Chapter 7. Cloning and analysis of natural product pathways</article-title>. <source>Methods Enzymol</source>
<volume>458</volume>:<fpage>159</fpage>&#x02013;<lpage>180</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0076-6879(09)04807-1</pub-id>.<pub-id pub-id-type="pmid">19374983</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jez</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Bowman</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Noel</surname>
<given-names>JP</given-names></string-name></person-group>. <year>2001</year>. <article-title>Structure-guided programming of polyketide chain-length determination in chalcone synthase</article-title>. <source>Biochemistry</source>
<volume>40</volume>:<fpage>14829</fpage>&#x02013;<lpage>14838</lpage>. doi:<pub-id pub-id-type="doi">10.1021/bi015621z</pub-id>.<pub-id pub-id-type="pmid">11732902</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hildebraunt</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Roots</surname>
<given-names>I</given-names></string-name></person-group>. <year>1975</year>. <article-title>Reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent formation and breakdown of hydrogen peroxide during mixed function oxidation reactions in liver microsomes</article-title>. <source>Arch Biochem Biophys</source>
<volume>171</volume>:<fpage>385</fpage>&#x02013;<lpage>397</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0003-9861(75)90047-8</pub-id>.<pub-id pub-id-type="pmid">955</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilkins</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Gasteiger</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bairoch</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sanchez</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Appel</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Hochstrasser</surname>
<given-names>DF</given-names></string-name></person-group>. <year>1999</year>. <article-title>Protein identification and analysis tools in the ExPASy server</article-title>. <source>Methods Mol Biol</source>
<volume>112</volume>:<fpage>531</fpage>&#x02013;<lpage>552</lpage>. doi:<pub-id pub-id-type="doi">10.1385/1-59259-584-7:531</pub-id>.<pub-id pub-id-type="pmid">10027275</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pedre</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Charlier</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mourenza</surname>
<given-names>&#x000c1;</given-names></string-name>, <string-name><surname>Rosado</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Marcos-Pascual</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wahni</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Martens</surname>
<given-names>E</given-names></string-name>, <string-name><surname>de la Rubia</surname>
<given-names>AG</given-names></string-name>, <string-name><surname>Belousov</surname>
<given-names>VV</given-names></string-name>, <string-name><surname>Mateos</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Messens</surname>
<given-names>J</given-names></string-name></person-group>. <year>2018</year>. <article-title>Structural snapshots of OxyR reveal the peroxidatic mechanism of H(2)O(2) sensing</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>115</volume>:<fpage>E11623</fpage>&#x02013;<lpage>E11632</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1807954115</pub-id>.<pub-id pub-id-type="pmid">30463959</pub-id></mixed-citation></ref></ref-list></back></article>